Citi Starts Arrowhead Pharma (ARWR) at Buy
Citi analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ: ARWR) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
